These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 3332004
1. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Minna JD, Battey JF, Birrer M, Brooks BJ, Cuttitta F, DeGreve J, Gazdar AF, Johnson BE, Nau MM, Sausville EA. Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004 [Abstract] [Full Text] [Related]
2. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). Lavialle C, Modjtahedi N, Lamonerie T, Frebourg T, Landin RM, Fossar N, Lhomond G, Cassingena R, Brison O. Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529 [Abstract] [Full Text] [Related]
3. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Gazzeri S, Brambilla E, Chauvin C, Jacrot M, Benabid AL, Brambilla C. Cancer Res; 1990 Mar 01; 50(5):1566-70. PubMed ID: 2154327 [Abstract] [Full Text] [Related]
4. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE, Battey J, Linnoila I, Becker KL, Makuch RW, Snider RH, Carney DN, Minna JD. J Clin Invest; 1986 Aug 01; 78(2):525-32. PubMed ID: 3016030 [Abstract] [Full Text] [Related]
6. Amplification of the N-myc oncogene in an adenocarcinoma of the lung. Saksela K, Bergh J, Nilsson K. J Cell Biochem; 1986 Aug 01; 31(4):297-304. PubMed ID: 3020069 [Abstract] [Full Text] [Related]
7. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers. Taya Y. Jpn J Clin Oncol; 1986 Sep 01; 16(3):199-202. PubMed ID: 3022029 [Abstract] [Full Text] [Related]
12. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, Sugimura T, Terada M. Oncogene; 1988 Jun 01; 2(6):607-11. PubMed ID: 2838790 [Abstract] [Full Text] [Related]
13. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F, Poupon MF, Le Chevalier T. Anticancer Res; 1994 Jun 01; 14(5A):1893-901. PubMed ID: 7847823 [Abstract] [Full Text] [Related]
15. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR. Oncogene; 2006 Jan 05; 25(1):130-8. PubMed ID: 16116477 [Abstract] [Full Text] [Related]
17. myc family gene abnormality in lung cancers and its relation to xenotransplantability. Gemma A, Nakajima T, Shiraishi M, Noguchi M, Gotoh M, Sekiya T, Niitani H, Shimosato Y. Cancer Res; 1988 Nov 01; 48(21):6025-8. PubMed ID: 3167852 [Abstract] [Full Text] [Related]
20. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE, Bepler G, Kubasch M, Havemann K. Cancer Res; 1987 Dec 01; 47(23):6236-42. PubMed ID: 2824028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]